EcoDrugPlus

Tumor Protein P53

Ensembl ID : ENSODEG00000017683
Gene Symbol: TP53
3 Cross references
253 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSODEG00000001858
Gene Symbol: TYR
3 Cross references
266 Possible Orthologues:

Tyrosine Hydroxylase

Ensembl ID : ENSODEG00000017061
Gene Symbol: TH
3 Cross references
187 Possible Orthologues:

Tyrosine Kinase 2

Ensembl ID : ENSODEG00000016347
Gene Symbol: TYK2
1 Cross references
196 Possible Orthologues:

Tyrosine Kinase With Immunoglobulin Like And Egf Like Domains 1

Ensembl ID : ENSODEG00000002098
Gene Symbol: TIE1
3 Cross references
203 Possible Orthologues:

Vitamin K Epoxide Reductase Complex Subunit 1

Ensembl ID : ENSODEG00000014946
Gene Symbol: VKORC1
3 Cross references
189 Possible Orthologues:

Xanthine Dehydrogenase

Ensembl ID : ENSODEG00000005786
Gene Symbol: XDH
3 Cross references
211 Possible Orthologues:

Ensembl ID : ENSODEG00000018531
Gene Symbol: -
Cross references: -
229 Possible Orthologues:

Ensembl ID : ENSODEG00000006504
Gene Symbol: -
Cross references: -
119 Possible Orthologues:

Ensembl ID : ENSODEG00000013410
Gene Symbol: -
Cross references: -
119 Possible Orthologues:

Ensembl ID : ENSODEG00000019071
Gene Symbol: -
Cross references: -
119 Possible Orthologues:

Ensembl ID : ENSODEG00000019239
Gene Symbol: -
Cross references: -
143 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).